Cargando…

Indian data on central nervous tumors: A summary of published work

Tumors of the central nervous system (CNS) constitute approximately 2% of all malignancies. Although relatively rare, the associated morbidity and mortality and the significant proportion of affected young and middle-aged individuals has a major bearing on the death-adjusted life years compared to o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dasgupta, Archya, Gupta, Tejpal, Jalali, Rakesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991137/ https://www.ncbi.nlm.nih.gov/pubmed/27606302 http://dx.doi.org/10.4103/2278-330X.187589

Ejemplares similares

MRI-based prediction of molecular subgrouping in medulloblastoma: images speak louder than words
por: Dasgupta, Archya, et al.
Publicado: (2019)

Gynecological cancers: A summary of published Indian data
por: Maheshwari, Amita, et al.
Publicado: (2016)

Summary of the published Indian data on chronic myeloid leukemia
por: Singhal, Manish K., et al.
Publicado: (2016)

Indian data on bone and soft tissue sarcomas: A summary of published study results
por: Ramaswamy, Anant, et al.
Publicado: (2016)

Updated systematic review and meta-analysis of extended adjuvant temozolomide in patients with newly diagnosed glioblastoma
por: Gupta, Tejpal, et al.
Publicado: (2023)

Editorial on the topic: Gynecological cancers: A summary of published Indian data
por: Shylasree, T. S., et al.
Publicado: (2016)

The Promise of Magnetic Resonance Imaging in Radiation Oncology Practice in the Management of Brain, Prostate, and GI Malignancies
por: Srinivasan, Shashank, et al.
Publicado: (2022)

Genitourinary cancers: Summary of Indian data
por: Yuvaraja, T. B., et al.
Publicado: (2016)

WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go?
por: Mani, Shakthivel, et al.
Publicado: (2023)

Breast cancer: An overview of published Indian data
por: Rangarajan, Bharath, et al.
Publicado: (2016)

Classifying primary central nervous system lymphoma from glioblastoma using deep learning and radiomics based machine learning approach - a systematic review and meta-analysis
por: Guha, Amrita, et al.
Publicado: (2022)

A randomized trial of stereotactic versus conventional radiotherapy in young patients with low-grade brain tumors: occupational therapy-based neurocognitive data
por: Chatterjee, Abhishek, et al.
Publicado: (2020)

EMBR-14. INFLUENCE OF MRI FEATURES ON THE SURVIVAL AND IMPACT ON INDIVIDUAL MOLECULAR SUBGROUPS: RESULT FROM 171 PATIENTS WITH MEDULLOBLASTOMA
por: Dasgupta, Archya, et al.
Publicado: (2021)

EMBR-17. DE-INTENSIFICATION OF RADIOTHERAPY IN RIGOROUSLY DEFINED LOW-RISK WNT-SUBGROUP MEDULLOBLASTOMA IS ASSOCIATED WITH UNACCEPTABLY HIGH RISK OF NEURAXIAL FAILURE: RESULTS FROM THE PROSPECTIVE FOR-WNT STUDY
por: Gupta, Tejpal, et al.
Publicado: (2021)

MMAP-08 CHEMO-REIRRADIATION (NORMOFRACTIONATED VS. HYPOFRACTIONATED) WITH OR WITHOUT BEVACIZUMAB IN RECURRENT ADULT DIFFUSE HIGH-GRADE GLIOMA (COBRA): PHASE III RANDOMIZED CONTROLLED TRIAL WITH A 2 X 2 FACTORIAL DESIGN
por: Baviskar, Yamini, et al.
Publicado: (2022)

Next-generation strategies for gene-targeted therapies of central nervous system disorders: A workshop summary
por: Morris, Jill A., et al.
Publicado: (2021)

Rare Primary Central Nervous System Tumors
por: Kubicky, Charlotte Dai, et al.
Publicado: (2014)

Molecular pathology of tumors of the central nervous system
por: Kristensen, B W, et al.
Publicado: (2019)

Clinical outcomes with high-dose-rate surface mould brachytherapy for intra-oral and skin malignancies involving head and neck region
por: Budrukkar, Ashwini, et al.
Publicado: (2017)

P1 publishable summary
por: The HiLumi LHC Collaboration
Publicado: (2013)

MiR-148a, a microRNA upregulated in the WNT subgroup tumors, inhibits invasion and tumorigenic potential of medulloblastoma cells by targeting Neuropilin 1
por: Yogi, Kedar, et al.
Publicado: (2015)

Magnetic resonance imaging in central nervous system tuberculosis
por: Trivedi, Richa, et al.
Publicado: (2009)

Pharmacokinetic Principles and Their Application to Central Nervous System Tumors
por: Straehla, Joelle P., et al.
Publicado: (2020)

Expanding the spectrum of “mesenchymal” tumors of the central nervous system
por: Pizzimenti, Cristina, et al.
Publicado: (2022)

Seventh Annual Report Summary Published
Publicado: (1995)

Liquid biopsy for pediatric central nervous system tumors
por: Bonner, Erin R., et al.
Publicado: (2018)

Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults
por: Weller, Michael, et al.
Publicado: (2023)

MEDB-27. Clinico-Radiological Outcomes in WNT-pathway Medulloblastoma: Retrospective Single Institutional Audit
por: Mani, Shakthivel, et al.
Publicado: (2022)

The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors
por: Rodriguez, Andrew, et al.
Publicado: (2023)

Drug Repositioning for Refractory Benign Tumors of the Central Nervous System
por: Tamura, Ryota
Publicado: (2023)

A Simplified Overview of World Health Organization Classification Update of Central Nervous System Tumors 2016
por: Gupta, Anshu, et al.
Publicado: (2017)

An Indian Publishing Medical Society
por: Ghose, Kristodhun
Publicado: (1868)

Modulation of Tumor Tolerance in Primary Central Nervous System Malignancies
por: Johnson, Theodore S., et al.
Publicado: (2012)

Predicting IDH subtype of grade 4 astrocytoma and glioblastoma from tumor radiomic patterns extracted from multiparametric magnetic resonance images using a machine learning approach
por: Kandalgaonkar, Pashmina, et al.
Publicado: (2022)

Tumors of the Central Nervous System: An Update
por: Mucignat-Caretta, Carla
Publicado: (2020)

Embryonal Tumors of the Central Nervous System in Children: The Era of Targeted Therapeutics
por: Kram, David E., et al.
Publicado: (2018)

Challenges and opportunities for managing pediatric central nervous system tumors in China
por: Pak‐Yin Liu, Anthony, et al.
Publicado: (2020)

BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors
por: Talloa, Dario, et al.
Publicado: (2022)

Pediatric Central Nervous System Tumor Overview and Emerging Treatment Considerations
por: Damodharan, Sudarshawn, et al.
Publicado: (2023)

Vascularisation of the central nervous system
por: Tata, Mathew, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hpqpmlv2l7supshlhi24ek406s